In pharmacokinetic modeling, what does the distribution phase of a two-compartment model represent?

Prepare thoroughly for the MDC Pharmacokinetics Exam with our detailed guidance. Utilize flashcards and multiple-choice questions, complete with hints and explanations, to excel in your test!

Multiple Choice

In pharmacokinetic modeling, what does the distribution phase of a two-compartment model represent?

Explanation:
The distribution phase in a two-compartment pharmacokinetic model reflects rapid equilibration of the drug between the central compartment (blood/plasma) and a peripheral tissue compartment after administration. This quick exchange causes the plasma concentration to fall steeply at first as drug moves from the central compartment into tissues. The rate of this transfer is governed by the inter-compartment rate constants, so this early, sharp decline is the alpha or distribution phase. Once the distribution between compartments nearly reaches quasi-equilibrium, the curve slows and the elimination process from the central compartment becomes the dominant driver of concentration decline, giving the slower beta phase. This phase is not about absorption (that would occur with extravascular dosing), not about the slower elimination from the body, and not about metabolic conversion. Those processes shape the later part of the curve or other aspects of pharmacokinetics, whereas the distribution phase specifically describes the rapid spread of the drug between central and peripheral compartments.

The distribution phase in a two-compartment pharmacokinetic model reflects rapid equilibration of the drug between the central compartment (blood/plasma) and a peripheral tissue compartment after administration. This quick exchange causes the plasma concentration to fall steeply at first as drug moves from the central compartment into tissues. The rate of this transfer is governed by the inter-compartment rate constants, so this early, sharp decline is the alpha or distribution phase. Once the distribution between compartments nearly reaches quasi-equilibrium, the curve slows and the elimination process from the central compartment becomes the dominant driver of concentration decline, giving the slower beta phase.

This phase is not about absorption (that would occur with extravascular dosing), not about the slower elimination from the body, and not about metabolic conversion. Those processes shape the later part of the curve or other aspects of pharmacokinetics, whereas the distribution phase specifically describes the rapid spread of the drug between central and peripheral compartments.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy